EUVIMEDEUVIMED entdecken
Open Access

Added value of inflammatory plasma biomarkers to pathologic biomarkers in predicting preclinical Alzheimer's disease

Haley Leclerc, Athene Kw Lee, Zachary J Kunicki, Jessica Alber iD

Journal of Alzheimer’s Disease · 2024

DOI: 10.1177/13872877241283692 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, 2024. Verfasst von Haley Leclerc und 3 weiteren Autor:innen. Beteiligte Einrichtung: Interdisciplinary Neuroscience Program, University of Rhode Island, Kingston, RI, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Biomarkers, Amyloid beta-Peptides, tau Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NIGMS NIH HHS, National Institute of General Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Plasma biomarkers have recently emerged for the diagnosis, assessment, and disease monitoring of Alzheimer's disease (AD), but have yet to be fully validated in preclinical AD. In addition to AD pathologic plasma biomarkers (amyloid-β (Aβ) and phosphorylated tau (p-tau) species), a proteomic panel can discriminate between symptomatic AD and cognitively unimpaired older adults in a dementia clinic population.

Objective

Examine the added value of a plasma proteomic panel, validated in symptomatic AD, over standard AD pathologic plasma biomarkers and demographic and genetic (apolipoprotein ( APOE) ɛ4 status) risk factors in detecting preclinical AD.

Methods

125 cognitively unimpaired older adults (mean age = 66 years) who completed Aβ PET and plasma draw were analyzed using multiple regression with Aβ PET status (positive versus negative) as the outcome to determine the best fit for predicting preclinical AD. Model 1 included age, education, and gender. Model 2 and 3 added predictors APOE ɛ4 status (carrier versus non-carrier) and AD pathologic blood biomarkers (Aβ 42/40 ratio, p-tau181), respectively. Random forest modeling established the 5 proteomic markers from the proteomic panel that best predicted Aβ PET status, and these markers were added in Model 4.

Results

The best model for predicting Aβ PET status included age, years of education, APOE ɛ4 status, Aβ 42/40 ratio, and p-tau181. Adding the top 5 proteomic markers did not significantly improve the model.

Conclusions

Proteomic markers in plasma did not add predictive value to standard AD pathologic plasma biomarkers in predicting preclinical AD in this sample.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseBiomarkersAmyloid beta-Peptidestau ProteinsPositron-Emission TomographyHumansFemaleMaleAgedMiddle AgedApolipoprotein E4ProteomicsPredictive Value of TestsPeptide FragmentsProdromal Symptoms

Stichwörter der Autor:innen

biomarkersearly diagnosisinflammationplasma proteomicspreclinical Alzheimer's disease

Substanzen

BiomarkersAmyloid beta-Peptidestau ProteinsApolipoprotein E4Peptide Fragments

Autor:innen und Institutionen

  • Interdisciplinary Neuroscience Program, University of Rhode Island, Kingston, RI, USA.
  • Butler Hospital Memory & Aging Program, Providence, RI, USA.
  • Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Providence, RI, USA.
  • Department of Biomedical and Pharmaceutical Sciences, University of Rhode Island, Kingston, RI, USA.

ORCID-Profile: Jessica Alber

Förderung

  • NIA NIH HHS
  • NIGMS NIH HHS
  • National Institute of General Medical Sciences

Zitieren

APA

Leclerc, H., Lee, A. K., Kunicki, Z. J., & Alber, J. (2024). Added value of inflammatory plasma biomarkers to pathologic biomarkers in predicting preclinical Alzheimer's disease. Journal of Alzheimer’s Disease. https://doi.org/10.1177/13872877241283692

Vancouver

Leclerc H, Lee AK, Kunicki ZJ, Alber J. Added value of inflammatory plasma biomarkers to pathologic biomarkers in predicting preclinical Alzheimer's disease. Journal of Alzheimer’s Disease. 2024. doi:10.1177/13872877241283692

BibTeX
@article{Leclerc2024,
  author = {Leclerc, Haley and Lee, Athene Kw and Kunicki, Zachary J and Alber, Jessica},
  title = {Added value of inflammatory plasma biomarkers to pathologic biomarkers in predicting preclinical Alzheimer's disease},
  journal = {Journal of Alzheimer’s Disease},
  year = {2024},
  doi = {10.1177/13872877241283692}
}
Kostenlos starten →